Propanc Biopharma, Inc. (PPCB) — 10-K Filings
All 10-K filings from Propanc Biopharma, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Propanc Biopharma Pushes Ahead with Cancer Stem Cell Therapy
— Sep 29, 2025 Risk: high
Propanc Biopharma, Inc. (PPCB) reported no revenue for the fiscal year ended June 30, 2025, continuing its development-stage status. The company is focused on i -
Propanc Biopharma Files 2024 10-K
— Sep 30, 2024 Risk: medium
Propanc Biopharma, Inc. filed its 10-K for the fiscal year ending June 30, 2024. The company, focused on pharmaceutical preparations, reported financial data fo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX